Rare diseases
Investigational molecules
Locations
Ul. Belgradzka 52/54, 02-793 Warsaw, Poland
Mcm Polimedica 2 Sp. z o.o. in Warsaw, Poland specialises in clinical trials of conditions such as Asthma, Atrial fibrillation, Chronic obstructive pulmonary disease, Alopecia areata, and other specialisations. This site conducts important research.
Researchers at Mcm Polimedica 2 are studying Chronic Heart Failure With Reduced Ejection Fraction to determine whether a new oral agent can lower the risk of cardiovascular death and heart‑failure hospitalization.
The trial involves a multidisciplinary team of 11 investigators and aims to improve long‑term survival for patients with severe cardiac dysfunction.
A study focusing on Chronic Obstructive Pulmonary Disease (COPD) evaluates the impact of benralizumab on reducing frequent exacerbations in patients with high peripheral blood eosinophils.
Conducted at the Warsaw clinic, this research seeks to provide a targeted biologic option for individuals with a history of severe COPD attacks.
The site is evaluating povorcitinib in adults with Chronic Spontaneous Urticaria to assess its ability to control persistent hives and improve patient quality of life.
This trial adds to the limited therapeutic options for chronic hives and involves collaboration among dermatology specialists at the facility.
Clinical trials currently enrolling participants at this site.
A study testing molnupiravir in adults with COVID-19 who are not hospitalized and are at high risk for serious illness
PolandPrevention of Stroke and Systemic Embolism in Atrial Fibrillation Patients Treated with REGN7508 (cenvacibart) versus Apixaban
PolandStudy on the Effectiveness of Beltavac with Grass Pollen Extract for Patients with Allergic Rhinoconjunctivitis and Possible Asthma
PolandStudy on the Effectiveness and Safety of Tocilizumab and Methotrexate for Adults with Moderate to Severe Rheumatoid Arthritis
PolandStudy on the Effects of BP16 and Denosumab in Women with Post-Menopausal Osteoporosis
PolandStroke and Systemic Embolism Prevention with REGN7508 and REGN9933 in Adults with Atrial Fibrillation Unsuitable for Oral Anticoagulation (Phase 3)
PolandStudy on the Effects of Astegolimab and Drug Combination for Patients with Chronic Obstructive Pulmonary Disease (COPD)
PolandStudy on Long-Term Safety and Efficacy of Deucravacitinib for Patients with Moderate-to-Severe Plaque Psoriasis
PolandStudy on Benralizumab for Patients with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) with Frequent Exacerbations
PolandComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
PolandStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
PolandLong-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata
PolandMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
